ZYME

ZYMEWORKS INC

ZYME·98985Y108·US·Common Stock·Healthcare - Biotechnology-Activist

ZYME (ZYMEWORKS INC) is held by 125 institutional investors as of Q1 2026. Largest holders: BlackRock, Inc. ($114M), MORGAN STANLEY ($62.1M), BNP Paribas Asset Management Holding S.A. ($47.8M). Net institutional sentiment: Mixed.

125
Holders
Avg rating(29 Elite)
$667.8M
Total Value
56% (136)
Fund Consensus
70 buying - 56 selling
ZYMESmart Money Verdict
View all
Held by 125 funds
29 elite
Who's Trading
ActivistRURubric Capital Management LP9.5%May 15, 2026
ActivistPAPerceptive Advisors LLC5.4%Apr 15, 2026
ActivistMorgan StanleyMorgan Stanley3.4%Feb 12, 2026
InsiderHMHollywood MarkSell $139KJan 12, 2026
InsiderGKGalbraith KennethSell $690KJan 12, 2026
InsiderMAMoore Paul AndrewSell $217KJan 12, 2026
InsiderSLSmith Jeffrey T LSell $211KJan 12, 2026
InsiderGKGalbraith KennethSell $1.3MDec 22, 2025
ActivistECEcoR1 Capital, LLC30.7%Nov 19, 2025
ActivistBVBIOTECHNOLOGY VALUE FUND L P2.7%Nov 14, 2025
13F: Insider & Congress:
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Decreased
4.6M(-0.9%)$114M0.0%+59.63%
0
Decreased
2.5M(-4.3%)$62.1M0.0%+179.59%
0
Increased
1.9M(+4.7%)$47.8M0.1%-2.14%
31
New
1.7M$42.7M0.0%+5.85%
40
Increased
1.2M(+350.4%)$28.8M0.0%+15.54%
46
Decreased
1.1M(-1.7%)$28.5M0.0%+161.91%
0
Decreased
1M(-2.5%)$25.3M0.0%+148.16%
0
Decreased
921,250(-42.3%)$23.1M0.0%+166.08%
0
Increased
743,898(+6.3%)$18.6M0.0%+15.07%
30
Increased
727,986(+12.4%)$18.2M0.0%+45.75%
32
Increased
667,153(+19.1%)$16.7M0.0%-1.01%
33
Increased
659,940(+1.9%)$16.5M0.0%+187.85%
29
Increased
651,662(+0.5%)$16.3M0.0%+81.03%
28
Increased
599,486(+42.7%)$15M0.0%+53.97%
38
Increased
511,937(+7.9%)$12.8M0.0%+22.66%
30
New
499,875$12.5M0.0%+5.85%
39
Increased
320,210(+4.0%)$8M0.0%+170.96%
29
Decreased
319,385(-0.3%)$8M0.0%+135.09%
0
New
299,202$7.5M0.1%+5.85%
38
Increased
256,690(+4.9%)$6.4M0.0%+123.27%
29

Showing 1-20 of 136

1 / 7

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used